Delivery Order SPE2DB20D2104-SPE2DB25FMBTT
Award Date 11/12/24
Potential Completion Date 11/13/24
Potential Value $8.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,320.24, is a Delivery Order for the procurement of STELARA 45 MG/0.5 ML SYRINGE 0.5ML, a specialty pharmaceutical product. The contract has an ultimate completion date of December 21, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the...
- This federal contract award, with an ID of SPE2DB22D3004|SPE2DB25FPD41, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,136.46, is for the delivery of STELARA 90 MG/ML SYRINGEML, a specialty medication. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $6,491.89, is for the delivery of STELARA 45 MG/0.5 ML SYRINGE 0.5ML, a specialty pharmaceutical product. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up...
- The federal contract award with ID SPE2DB24D1205|SPE2DB25FCSDC was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $121,097.98 firm fixed-price delivery order contract is for the supply of STELARA 90 MG/ML syringes, with a completion date of December 5, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop...
- This federal contract award, identified as SPE2DB20D2104|SPE2DB23FT41M, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,991.41, is for the delivery of STELARA 45 MG/0.5 ML SYRINGE 0.5ML, a specialty medication. This is a delivery order contract with a firm fixed price pricing type, having an ultimate completion date of May 9, 2023. The contract does not have a...
- This federal contract award, with ID SPE2DB24D1021|SPE2DB25FERSQ, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $10,685.58 firm fixed-price contract is for the delivery of the pharmaceutical product STELARA 45 MG/0.5 ML SYRINGE 0.5ML. The contract has an ultimate completion date of October 31, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that provides a wide range of medical supplies, medications, and...
- This federal contract award, with ID SPE2DB20D2104|SPE2DB24FV75S, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $8,598.19 firm fixed-price delivery order is for the pharmaceutical product STELARA 90 MG/ML SYRINGE. The contract has an ultimate completion date of August 19, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies,...
- This federal contract award, with ID SPE2DB24D2100|SPE2DB25FBCGK, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,777.46, is a delivery order for the supply of 4567302288 - STELARA 45 MG/0.5 ML SYRINGE 0.5ML. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,322.35 firm fixed-price delivery order is for the supply of 4563283908 - STELARA 45 MG/0.5 ML SYRINGE 0.5ML, with a completion date of January 10, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which...
- This federal contract award, with ID SPE2DB22D3301|SPE2DB25FY3MM, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $42,687.44 firm fixed-price delivery order is for the supply of 4567968852 STELARA 45 MG/0.5 ML SYRINGE 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of April 21, 2025 and was awarded on April 18, 2025. Amerisourcebergen Drug Corp is the prime...